Endo Held Liable in U.S. Opioid Case After Default Judgment
(Bloomberg) -- A judge in Tennessee found Endo International Plc liable in an opioid-marketing case by default and is stripping the company of its legal defenses in an upcoming trial.
Stay updated with breaking news from Matthew Maletta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Bloomberg) -- A judge in Tennessee found Endo International Plc liable in an opioid-marketing case by default and is stripping the company of its legal defenses in an upcoming trial.
By Reuters Staff 2 Min Read WASHINGTON (Reuters) - The U.S. Federal Trade Commission said on Monday it has filed a lawsuit against Endo Pharmaceuticals and Impax Laboratories that alleges a 2017 agreement eliminated competition between the companies for the pain medicine oxymorphone ER. In addition to Endo Pharmaceuticals Inc and Impax Laboratories LLC, the lawsuit names as defendants Endo International Plc and Impax’s owner, Amneal Pharmaceuticals Inc, the agency said. The U.S. Food and Drug Administration had asked Endo in June 2017 to pull its extended-release oxymorphone product off the...